Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Akebia Therapeutics (NASDAQ:AKBA) through any online brokerage.
Other companies in Akebia Therapeutics’s space includes: Cabaletta Bio Inc (NASDAQ:CABA), Monopar Therapeutics Inc (NASDAQ:MNPR), Immuneering Corp (NASDAQ:IMRX), Altimmune Inc (NASDAQ:ALT) and Palisade Bio Inc (NASDAQ:PALI).
Akebia Therapeutics has a consensus price target of $5.50.
The stock price for Akebia Therapeutics (NASDAQ: AKBA) is $1.4326 last updated April 24, 2026 at 4:51 PM EDT.
There are no upcoming dividends for Akebia Therapeutics.
Akebia Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Akebia Therapeutics.
Akebia Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.